Each year NIH Technology Transfer releases a list of the top 20 royalty-on-sales grossing products of the year based upon license agreements to inventions made by the NIH intramural research program. The list is broken down into four categories: vaccines and therapeutics, diagnostics

A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have

The National Institute of Allergy and Infectious Diseases (NIAID) won a 2022 FLC award for Excellence in Technology Transfer, as well as received the COVID-19 Response Distinction, for their antibody-focused collaboration with AbCellera. This collaboration was established in 2018 through a Research